Public-registry trials using TTAC-0001 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab | PharmAbcine | Recurrent Glioblastoma | PHASE2 | 3 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →